Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Wullenkord, Ramona, Reicherts, Christian, Mikesch, Jan-Henrik, Marx, Julia, Wethmar, Klaus, Albring, Jörn, Call, Simon, Lenz, Georg, Stelljes, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817557/
https://www.ncbi.nlm.nih.gov/pubmed/32829460
http://dx.doi.org/10.1007/s00277-020-04227-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817557/
https://www.ncbi.nlm.nih.gov/pubmed/32829460
http://dx.doi.org/10.1007/s00277-020-04227-8

Ejemplares similares